Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| local anaesthetics | 3051 | 94-25-7 |
None
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 2.757 | Moderate | 0.69 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 0.212 | Moderate | 0.69 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 69.663 | 10^-6 cm/s | Moderate | 0.69 |
| dh-clint | Dog hepatocyte intrinsic clearance | 561.048 | uL/min/10^6 cells | Moderate | 0.69 |
| dppb | Dog plasma protein binding (% unbound) | 7.930 | % | Moderate | 0.69 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 12.890 | % | Moderate | 0.69 |
| herg | hERG pIC50 | 4.380 | pIC50 | Moderate | 0.69 |
| hh-clint | Human hepatocyte intrinsic clearance | 554.626 | uL/min/10^6 cells | Moderate | 0.69 |
| hlm-clint | Human liver microsomal intrinsic clearance | 364.754 | uL/min/mg protein | Moderate | 0.69 |
| hppb | Human plasma protein binding (% unbound) | 7.810 | % | Moderate | 0.69 |
| kinase-safety-class | ACVR2A,ACVR2B,AKT2,AKT3,ALK,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,FLT3,GRK2,GRK3,GSK3B,ITK,JAK1,JAK2,MAP2K6,MAP3K1,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK7,MAPK9,MAPKAPK2,MARK4,MET,MTOR,NTRK2,PAK4,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PLK1,PRKCD,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TTK,ULK1 | 55 | |||
| kinase-selectivity-class | AURKA,AXL,DYRK1B,GRK2,MAP2K6,MAPK7,STK33,TEK,TTK | 9 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 0.303 | Moderate | 0.69 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 1140.250 | Moderate | 0.69 | |
| mppb | Mouse plasma protein binding (% unbound) | 8.750 | Moderate | 0.69 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 0.212 | Moderate | 0.69 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 16.320 | % | Moderate | 0.69 |
| rh-clint | Rat hepatocyte intrinsic clearance | 265.461 | uL/min/10^6 cells | Moderate | 0.69 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 89.310 | % | Moderate | 0.69 |
| rppb | Rat plasma protein binding (% unbound) | 9.090 | % | Moderate | 0.69 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 134.276 | uM | Moderate | 0.69 |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000777 | Anesthetics |
| MeSH PA | D000779 | Anesthetics, Local |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D002492 | Central Nervous System Depressants |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D018689 | Sensory System Agents |
| CHEBI has role | CHEBI:36333 | local anaesthetic |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Skin irritation | indication | 367466007 | |
| Itching of skin | indication | 418363000 | |
| Minor Skin Wound Pain | indication | ||
| Conduction disorder of the heart | contraindication | 44808001 | |
| Decreased respiratory function | contraindication | 80954004 | |
| Open wound | contraindication | 125643001 | |
| Seizure disorder | contraindication | 128613002 | |
| Denuded skin | contraindication | 418242004 |
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 2.5 | Basic |
None
None
None
| ID | Source |
|---|---|
| 4019648 | VUID |
| N0000147741 | NUI |
| D00730 | KEGG_DRUG |
| 4019648 | VANDF |
| C0054235 | UMLSCUI |
| CHEMBL127516 | ChEMBL_ID |
| DB11148 | DRUGBANK_ID |
| 2482 | PUBCHEM_CID |
| C004605 | MESH_SUPPLEMENTAL_RECORD_UI |
| EFW857872Q | UNII |
| 19861 | RXNORM |
| 14814 | MMSL |
| 001368 | NDDF |
| 108929004 | SNOMEDCT_US |
| 48078005 | SNOMEDCT_US |
| CHEBI:3231 | CHEBI |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Cetacaine Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0201 | AEROSOL, SPRAY | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 12 sections |
| Cetacaine Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0202 | SOLUTION | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 12 sections |
| Cetacaine Topical Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0217 | GEL | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 11 sections |
| Cetacaine Topical Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0221 | GEL | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 11 sections |
| Cetacaine Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0225 | SOLUTION | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 12 sections |
| Cetacaine Anesthetic | HUMAN PRESCRIPTION DRUG LABEL | 3 | 10223-0226 | SOLUTION | 0.00 g | TOPICAL | UNAPPROVED DRUG OTHER | 12 sections |